Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Vanda Pharmaceuticals stock (VNDA)

Buy Vanda Pharmaceuticals stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Vanda Pharmaceuticals is a biotechnology business based in the US. Vanda Pharmaceuticals shares (VNDA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.59 – a decrease of 3.16% over the previous week. Vanda Pharmaceuticals employs 203 staff and has a trailing 12-month revenue of around $182 million.

Our top picks for where to buy Vanda Pharmaceuticals stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

Our pick for investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Vanda Pharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – VNDA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Vanda Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
eToro
Finder Score: 4 / 5: ★★★★★
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.9%
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Vanda Pharmaceuticals stock price (NASDAQ: VNDA)

Use our graph to track the performance of VNDA stocks over time.

Vanda Pharmaceuticals shares at a glance

Information last updated 2024-10-01.
Latest market close$4.59
52-week range$3.30 - $6.75
50-day moving average $5.27
200-day moving average $4.80
Wall St. target price$8.07
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.19

Is it a good time to buy Vanda Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Vanda Pharmaceuticals price performance over time

Historical closes compared with the close of $4.59 from 2024-10-02

1 week (2024-09-26) -3.16%
1 month (2024-09-03) -9.65%
3 months (2024-07-03) -14.37%
6 months (2024-04-03) -9.11%
1 year (2023-10-03) 11.14%
2 years (2022-10-03) -54.64%
3 years (2021-10-01) 17.78
5 years (2019-10-03) 13.385

Vanda Pharmaceuticals financials

Revenue TTM $182 million
Gross profit TTM $230.1 million
Return on assets TTM -3.14%
Return on equity TTM -2.02%
Profit margin -6%
Book value $9.31
Market Capitalization $273.4 million

TTM: trailing 12 months

N/A

Vanda Pharmaceuticals share dividends

We're not expecting Vanda Pharmaceuticals to pay a dividend over the next 12 months.

Vanda Pharmaceuticals share price volatility

Over the last 12 months, Vanda Pharmaceuticals's shares have ranged in value from as little as $3.295 up to $6.75. A popular way to gauge a stock's volatility is its "beta".

VNDA.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vanda Pharmaceuticals's is 0.775. This would suggest that Vanda Pharmaceuticals's shares are less volatile than average (for this exchange).

Vanda Pharmaceuticals overview

Vanda Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, delayed sleep phase disorder, sleep disturbances in autism spectrum disorder, and pediatric Non-24; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia. The company's pipeline products also include VTR-297, a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders; VHX-896, an active metabolite of iloperidone; and antisense oligonucleotide molecules. In addition, it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; and VPO-227 for the treatment of secretory diarrhea disorders comprising cholera. Vanda Pharmaceuticals Inc.

Frequently asked questions

What percentage of Vanda Pharmaceuticals is owned by insiders or institutions?
Currently 3.16% of Vanda Pharmaceuticals shares are held by insiders and 77.537% by institutions.
How many people work for Vanda Pharmaceuticals?
Latest data suggests 203 work at Vanda Pharmaceuticals.
When does the fiscal year end for Vanda Pharmaceuticals?
Vanda Pharmaceuticals's fiscal year ends in December.
Where is Vanda Pharmaceuticals based?
Vanda Pharmaceuticals's address is: 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037
What is Vanda Pharmaceuticals's ISIN number?
Vanda Pharmaceuticals's international securities identification number is: US9216591084
What is Vanda Pharmaceuticals's CUSIP number?
Vanda Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 921659108

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site